Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
ASG.Vthis companyAurora Spine Corporation	CA$0.11	-20.7×	4.02×	0.83×	23.82×	987.9%	24.6%	-1.8%	-4.1%	-19.5%	-4.3%	2.7%	0.93×	3.51×	-1.12×	2.33×	0.0%	5	-1.78	1	D+
BCT.TOBriaCell Therapeutics Corp.	CA$5.51	-0.68×	1.47×	0×	-0.39×	-83.3%	0.0%	0.0%	0.0%	-216.0%	-234.6%	-120.9%	0×	0.27×	0×	2.76×	0.0%	1	-10.15	2	C
DOSE.CNRapid Dose Therapeutics Corp.	CA$0.11	-5.88×	-2.78×	7.19×	-15.23×	-398.4%	-34.5%	-78.3%	-122.2%	47.2%	117.1%	-1.4%	-0.74×	-3.2×	-1.78×	0.04×	0.0%	3	-27.84	2	C
GWAY.CNGreenway Greenhouse Cannabis Corporation	CA$0.08	-8.81×	2.91×	3.02×	82.82×	-4824.0%	2.5%	-19.3%	-34.4%	-33.1%	-6.2%	-8.9%	2.01×	32.35×	-1.17×	0.48×	0.0%	1	-0.99	—	—
HEM.VHemostemix Inc.	CA$0.05	-3.13×	-2.96×	0×	-4.14×	-154.2%	0.0%	0.0%	0.0%	94.8%	637.9%	-30.8%	-0.72×	-0.69×	-10.05×	0.49×	0.0%	1	-454.38	2	C
NARA.CNPangenomic Health Inc.	CA$0.30	-2.42×	-3.87×	0×	-2.53×	-135.1%	0.0%	0.0%	0.0%	156.8%	173.2%	-22.2%	-0.1×	-0.05×	-835.72×	0.07×	0.0%	2	-346.8	—	—
Peer median	—	-3.13×	-2.78×	0×	-2.53×	-154.2%	0.0%	0.0%	0.0%	47.2%	117.1%	-22.2%	-0.1×	-0.05×	-1.78×	0.48×	0.0%	1	-27.84	2	—